Folate-methotrexate loaded bovine serum albumin nanoparticles preparation: an in vitro drug targeting cytokines overwhelming expressed immune cells from rheumatoid arthritis patients

References

• Catrina AI, Svensson CI, Malmström V, et al. Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13(2):79–86.
   PubMed Web of Science ®Google Scholar
• Combe B, Landewé R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66(1):34–45.
   PubMed Web of Science ®Google Scholar
• Gavrilă B, Ciofu C, Stoica V. Biomarkers in rheumatoid arthritis, what is new? J Med Life. 2016;9(2):144–148.
   PubMedGoogle Scholar
• Wasserman AM. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2011;84(11):1245–1252.
   PubMed Web of Science ®Google Scholar
• Silva-Fernandes T, Duarte LC, Carvalheiro F, et al. Hydrothermal pretreatment of several lignocellulosic mixtures containing wheat straw and two hardwood residues available in Southern Europe. Bioresour Technol. 2015;183:213–220.
   PubMed Web of Science ®Google Scholar
• Brennan FM, McInnes IBJ. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008;118(11):3537–3545.
   PubMed Web of Science ®Google Scholar
• Evavold CL, Ruan J, Tan Y, et al. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity. 2018;48(1):35–44.e6.
   PubMed Web of Science ®Google Scholar
• Smeets T, Barg E, Kraan M, et al. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis. 2003;62(7):635–638.
   PubMed Web of Science ®Google Scholar
• Nakahara H, Song J, Sugimoto M, et al. Anti–interleukin‐6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheumatism. 2003;48(6):1521–1529.
   PubMed Web of Science ®Google Scholar
• Karampetsou MP, Comte D, Suárez‐Fueyo A, et al. Signaling lymphocytic activation molecule family member 1 engagement inhibits T cell-B cell interaction and diminishes interleukin-6 production and plasmablast differentiation in systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(1):99–108.
   PubMed Web of Science ®Google Scholar
• Dienz O, Eaton SM, Bond JP, et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J Exp Med. 2009;206(1):69–78.
   PubMed Web of Science ®Google Scholar
• Ursini F, Leporini C, Bene F, et al. Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis. Sci Rep. 2017;7(1):5346.
   PubMedGoogle Scholar
• Hambardzumyan K. Predictive Biomarkers in Rheumatoid Arthritis. Ph.D. thesis. Karolinska Institutet, Stockholm, Sweden. 2018.
   Google Scholar
• Noack M, Miossec P. Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol. 2017;39:365–383.
   Google Scholar
• Niu X, Chen G. Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritis. J Immunol Res. 2014;2014:698192.
   PubMed Web of Science ®Google Scholar
• Jain S, Mathur R, Das M, et al. Synthesis, pharmacoscintigraphic evaluation and antitumor efficacy of methotrexate-loaded, folate-conjugated, stealth albumin nanoparticles. Nanomedicine. 2011;6(10):1733–1754.
   PubMed Web of Science ®Google Scholar
• Ochekpe NA, Olorunfemi PO, Ngwuluka NC. Nanotechnology and drug delivery part 1: background and applications. Trop J Pharm Res. 2009;8(3):265–274.
   Web of Science ®Google Scholar
• Nikalje AP. Nanotechnology and its applications in medicine. Med Chem. 2015;5(2):081–089.
   Google Scholar
• Sahoo SK, Misra R, Parveen S. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed Cancer. 2017;8:73–124.
   Google Scholar
• Jahangirian H, Lemraski EG, Webster TJ, et al. A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine. Int J Nanomedicine. 2017;12:2957–2978.
   PubMed Web of Science ®Google Scholar
• Jahanban-Esfahlan A, Dastmalchi S, Davaran S. A simple improved desolvation method for the rapid preparation of albumin nanoparticles. Int J Biol Macromol. 2016;91:703–709.
   PubMed Web of Science ®Google Scholar
• Valdebenito A, Espinoza P, Lissi E, et al. Bovine serum albumin as chain transfer agent in the acrylamide polymerization. Protein-polymer conjugates. Polymer. 2010;51(12):2503–2507.
   Web of Science ®Google Scholar
• Wongsasulak S, Kit KM, McClements DJ, et al. The effect of solution properties on the morphology of ultrafine electrospun egg albumen–PEO composite fibers. Polymer. 2007;48(2):448–457.
   Web of Science ®Google Scholar
• Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release. 2008;132(3):171–183.
   PubMed Web of Science ®Google Scholar
• Salehiabar M, Nosrati H, Javani E, et al. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery. Int J Biol Macromol. 2018;115:83–89.
   PubMed Web of Science ®Google Scholar
• Ohwada K, Tamura K. Usefulness of alpha 1 acid glycoprotein (alpha 1-AG) values in screening pound dogs acquired from animal shelters for experimental use. Jikken Dobutsu. 1993;42(4):627–630.
   PubMed Web of Science ®Google Scholar
• Bilthariya U, Jain N, Rajoriya V, et al. Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib. Drug Dev Ind Pharm. 2015;41(1):95–104.
   PubMed Web of Science ®Google Scholar
• Qi L, Guo Y, Luan J, et al. Folate-modified bexarotene-loaded bovine serum albumin nanoparticles as a promising tumor-targeting delivery system. J Mater Chem B. 2014;2(47):8361–8371.].
   PubMed Web of Science ®Google Scholar
• Mahmood RI, Abbass AK, Al-Saffar AZ, et al. An in vitro cytotoxicity of a novel pH-Sensitive lectin loaded-cockle shell-derived calcium carbonate nanoparticles against MCF-7 breast tumour cell. J Drug Delivery Sci Technol. 2021;61:102230.
   Web of Science ®Google Scholar
• Jang JH, Jeong SH, Lee YB. Preparation and in vitro/in vivo characterization of polymeric nanoparticles containing methotrexate to improve lymphatic delivery. IJMS. 2019;20(13):3312.
   Google Scholar
• Panda SK, Kumar S, Tupperwar NC, et al. Chitohexaose activates macrophages by alternate pathway through TLR4 and blocks endotoxemia. PLOS Pathog. 2012;8(5):e1002717.
   PubMed Web of Science ®Google Scholar
• Merodio M, Arnedo A, Renedo MJ, et al. Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties. Eur J Pharm Sci. 2001;12(3):251–259.
   PubMed Web of Science ®Google Scholar
• Ni Y, Su S, Kokot S. Spectrofluorimetric studies on the binding of salicylic acid to bovine serum albumin using warfarin and ibuprofen as site markers with the aid of parallel factor analysis. Anal Chim Acta. 2006;580(2):206–215.
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang W. Numerical simulation of the geometrical factors affecting surface roughness measurements by AFM. Meas Sci Technol. 2004;15(10):2005–2010.
   Web of Science ®Google Scholar
• Bello AE, Perkins EL, Jay R, et al. Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis. Open Access Rheumatol. 2017;9:67–79.
   PubMed Web of Science ®Google Scholar
• Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000;343(22):1586–1593.
   PubMed Web of Science ®Google Scholar
• Drosos AA. Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives? Drugs Aging. 2003;20(10):723–736.
   PubMed Web of Science ®Google Scholar
• Hazlewood GS, Barnabe C, Tomlinson G, et al. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: a network meta‐analysis. Cochrane Database Syst Rev. 2016;(8)CD010227. doi:10.1002/14651858.CD010227.pub2
   PubMedGoogle Scholar
• Seymour H, Worsley A, Smith J, et al. Anti-TNF agents for rheumatoid arthritis. Br J Clin Pharmacol. 2001;51(3):201–208.
   PubMed Web of Science ®Google Scholar
• Van Schouwenburg PA, Rispens T, Wolbink GJ. Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis. Nat Rev Rheumatol. 2013;9(3):164–172.
   PubMed Web of Science ®Google Scholar
• Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295(19):2275–2285.
   PubMed Web of Science ®Google Scholar
• Atzeni F, Sarzi-Puttini P, Botsios C, et al. Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. Autoimmun Rev. 2012;12(2):225–229.
   PubMed Web of Science ®Google Scholar
• Nishino J, Tanaka S, Kadono Y, et al. The usefulness of neutrophil CD64 expression in the diagnosis of local infection in patients with rheumatoid arthritis in daily practice. J Orthopaed Sci. 2010;15(4):547–552.
   PubMed Web of Science ®Google Scholar
• Torun S, Tunc BD, Suvak B, et al. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity. Clin Res Hepatol Gastroenterol. 2012;36(5):491–497.
   PubMed Web of Science ®Google Scholar
• Ahsen A, Ulu MS, Yuksel S, et al. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation. 2013;36(6):1357–1362.
   PubMed Web of Science ®Google Scholar
• Rajendran K, Devarajan N, Ganesan M, et al. Obesity, Inflammation and Acute Myocardial Infarction - Expression of leptin, IL-6 and high sensitivity-CRP in Chennai based population. Thromb J. 2012;10(1):13.
   PubMedGoogle Scholar
• Janko C, Franz S, Munoz LE, et al. CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation. Front Immunol. 2011;2:70.
   PubMed Web of Science ®Google Scholar
• Dwivedi S, Singh S, Jaiswal G. Levels of hemoglobin, ESR, iron & TIBC in rheumatoid arthritis patients compared with normal individuals. J Med Sci Clin Res. 2016;4(3):9802–9807.
   Google Scholar
• Jones G, Nash P, Hall S. Advances in rheumatoid arthritis. Med J Aust. 2017;206(5):221–224.
   PubMed Web of Science ®Google Scholar
• Westwood OM, Nelson PN, Hay FC. Rheumatoid factors: what's new? Rheumatology. 2006;45(4):379–385.
   PubMed Web of Science ®Google Scholar
• Rakieh C, Nam J, Hunt L, et al. Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann Rheum Dis. 2015;74(9):1659–1666.
   PubMed Web of Science ®Google Scholar
• Ioan-Facsinay A, el-Bannoudi H, Scherer HU, et al. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ann Rheum Dis. 2011;70(1):188–193.
   PubMed Web of Science ®Google Scholar
• Mamehara A, Sugimoto T, Sugiyama D, et al. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs. Kobe J Med Sci. 2010;56(3):E98–107.
   PubMedGoogle Scholar
• Van der Heijde D, Van't Hof M, Van Riel P, et al. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis. 1992;51(2):177–181.
   PubMed Web of Science ®Google Scholar
• Siemons L, Vonkeman HE, Peter M, et al. Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker. Clin Rheumatol. 2014;33(6):783–789.
   PubMed Web of Science ®Google Scholar
• Snir O, Widhe M, Hermansson M, et al. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum. 2010;62(1):44–52.
   PubMedGoogle Scholar
• Amara K, Steen J, Murray F, et al. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med. 2013;210(3):445–455.
   PubMed Web of Science ®Google Scholar
• Anquetil F, Clavel C, Offer G, et al. IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies. J Immunol. 2015;194(8):3664–3674.
   PubMed Web of Science ®Google Scholar
• Rombouts Y, Ewing E, van de Stadt LA, et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis. 2015;74(1):234–241.
   PubMed Web of Science ®Google Scholar
• Bendtzen K. Immunogenicity of anti-TNF-α biotherapies: II. Clinical relevance of methods used for anti-drug antibody detection. Front Immunol. 2015;6:109.
   PubMed Web of Science ®Google Scholar
• Bos WH, Wolbink GJ, Boers M, et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis. 2010;69(3):490–494.
   PubMed Web of Science ®Google Scholar
• van de Stadt LA, van der Horst AR, de Koning MH, et al. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Ann Rheum Dis. 2011;70(1):128–133.
   PubMed Web of Science ®Google Scholar
• Laurent L, Anquetil F, Clavel C, et al. IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies. Ann Rheum Dis. 2015;74(7):1425–1431.
   PubMed Web of Science ®Google Scholar
• Sokolove J, Zhao X, Chandra PE, et al. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor. Arthritis Rheum. 2011;63(1):53–62.
   PubMedGoogle Scholar
• Lood C, Allhorn M, Lood R, et al. IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment? Arthritis Rheum. 2012;64(8):2698–2706.
   PubMedGoogle Scholar
• Boddu SH, Vaishya R, Jwala J, et al. Preparation and characterization of folate conjugated nanoparticles of doxorubicin using PLGA-PEG-FOL polymer. Med Chem. 2012;02 (04):68–75.
   Google Scholar
• Taheri A, Atyabi F, Nouri FS, et al. Nanoparticles of conjugated methotrexate-human serum albumin: preparation and cytotoxicity evaluations. J Nanomater. 2011;2011:1–7.
   PubMed Web of Science ®Google Scholar
• Bronze-Uhle E, Costa B, Ximenes V, et al. Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid. Nanotechnol Sci Appl. 2017;10:11–21.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liang L, Tian Z, et al. Preparation and in vitro evaluation of calcium-induced soy protein isolate nanoparticles and their formation mechanism study. Food Chem. 2012;133(2):390–399.
   PubMed Web of Science ®Google Scholar
• Sripriyalakshmi S, Anjali CH, George PDC, Rajith B, Ravindran A. BSA nanoparticle loaded atorvastatin calcium-a new facet for an old drug. PLOS One. 2014;9(2):e86317.
   PubMed Web of Science ®Google Scholar
• Zhao D, Zhao X, Zu Y. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomed. 2010;5(669):669–677.
   PubMedGoogle Scholar
• Von Storp B, Engel A, Boeker A, et al. Albumin nanoparticles with predictable size by desolvation procedure. J Microencapsul. 2012;29(2):138–146.
   PubMed Web of Science ®Google Scholar
• Salem M, Mauguen Y, Prangé T. Revisiting glutaraldehyde cross-linking: the case of the Arg-Lys intermolecular doublet. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010;66(Pt 3):225–228.
   PubMedGoogle Scholar
• Rahimnejad M, Jahanshahi M, Najafpour G. Production of biological nanoparticles from bovine serum albumin for drug delivery. African J Biotechnol. 2006;5(20):1918–1923.
   Google Scholar
• Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci. 2013;48(3):416–427.
   PubMed Web of Science ®Google Scholar
• Gawde KA, Kesharwani P, Sau S, et al. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue. J Colloid Interface Sci. 2017;496:290–299.
   PubMed Web of Science ®Google Scholar
• Kim H, Jo A, Baek S, et al. Synergistically enhanced selective intracellular uptake of anticancer drug carrier comprising folic acid-conjugated hydrogels containing magnetite nanoparticles. Sci Rep. 2017;7:41090.
   PubMed Web of Science ®Google Scholar
• Li L, Gao F, Jiang W, et al. Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging. Drug Deliv. 2016;23(5):1726–1733.
   PubMed Web of Science ®Google Scholar
• Shoda H, Nagafuchi Y, Tsuchida Y, et al. Increased serum concentrations of IL-1 beta, IL-21 and Th17 cells in overweight patients with rheumatoid arthritis. Arthritis Res. 2017;19(1):111.
   Google Scholar
• Mateen S, Moin S, Shahzad S, et al. Level of inflammatory cytokines in rheumatoid arthritis patients: correlation with 25-hydroxy vitamin D and reactive oxygen species. PLOS One. 2017;12(6):e0178879.
   PubMed Web of Science ®Google Scholar
• Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology. 2004;43(suppl_3):iii2–iii9.
   PubMed Web of Science ®Google Scholar
• Ogata A, Kato Y, Higa S, et al. IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review. Mod Rheumatol. 2019;29(2):258–267.
   PubMed Web of Science ®Google Scholar
• Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology. 2012;51(suppl 5):v3–v11.
   PubMed Web of Science ®Google Scholar
• Lin Y-K, Huang Z-R, Zhuo R-Z, et al. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomed. 2010;5(117):117–128.
   PubMedGoogle Scholar
• Zhang N, Wardwell PR, Bader RA. In vitro efficacy of polysaccharide-based nanoparticles containing disease-modifying antirheumatic drugs. Pharm Res. 2014;31(9):2326–2334.
   PubMed Web of Science ®Google Scholar
• Dubey RD, Alam N, Saneja A, et al. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine. Int J Pharm. 2015;492(1–2):80–91.
   PubMedGoogle Scholar
• Sung J-Y, Hong J-H, Kang H-S, et al. Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis. Immunopharmacology. 2000;47(1):35–44.
   PubMedGoogle Scholar
• Lima SAC, Reis S. Temperature-responsive polymeric nanospheres containing methotrexate and gold nanoparticles: a multi-drug system for theranostic in rheumatoid arthritis. Colloids Surf B Biointerfaces. 2015;133:378–387.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lee SH, Feng S-S. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials. 2007;28(10):1889–1899.
   PubMed Web of Science ®Google Scholar